Latest Breaking News On - Pharmaceutical industry and stock news - Page 1 : vimarsana.com

Halozyme Therapeutics Scores RS Rating Jump To 91

On Friday, Halozyme Therapeutics stock earned an upgrade to its Relative Strength (RS) Rating, from 80 to 91.

San diegoUnited statesHalozyme therapeuticsRelative strengthHalozyme therapeutics stockUnited therapeuticsPharmaceutical industry and stock news

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine biosciencesAlpine immune sciencesRelative strengthHalozyme therapeuticsPharmaceutical industry and stock news

Sarepta Therapeutics Stock Shows Improved Technical Strength

Sarepta Therapeutics Stock Shows Improved Technical Strength
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

United kingdomNeurocrine biosciencesAlpine immune sciencesRelative strengthSarepta therapeuticsSarepta therapeutics stockHalozyme therapeuticsPharmaceutical industry and stock news

Amgen Stock Sees Relative Strength Rating Improve To 74

Amgen Stock Sees Relative Strength Rating Improve To 74
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine biosciencesCatalyst pharmaceuticalsRelative strengthAmgen stockPharmaceutical industry and stock news

Ultragenyx Pharm Stock Hits 80-Plus Relative Strength Rating Benchmark

Ultragenyx Pharm Stock Hits 80-Plus Relative Strength Rating Benchmark
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine biosciencesUltragenyx pharmCatalyst pharmaceuticalsRelative strengthUltragenyx pharm stockFor the next big stock marketStart with thesePharmaceutical industry and stock news